Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/19/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 4.8k | $0.00 | $0 | | 05/19/2022 |
05/19/2022 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 15.3k | $35.42 | $542.6k | | 05/19/2022 |
02/18/2022 | Compass Therapeutics, Inc. | CMPX | Grant | Stock Option (Right to Buy) | 30k | $2.40 | $72k | | 02/18/2022 |
05/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 1.1k | $0.00 | $0 | | 05/20/2021 |
05/20/2021 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 7k | $75.94 | $531.4k | | 05/20/2021 |
04/28/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 19.2k | $76.20 | $1.5M | | 04/27/2021 |
04/27/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 201 | $75.05 | $15.1k | | 04/27/2021 |
04/19/2021 | Chemomab Therapeutics Ltd. | ANCN | Grant | Option to Purchase American Depositary Shares | 23.8k | $27.26 | $647.9k | | 04/19/2021 |
04/15/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 1.1k | $75.01 | $79.3k | | 04/14/2021 |
04/14/2021 | SpringWorks Therapeutics, Inc. | SWTX | Sale | Common Stock | 511 | $75.08 | $38.4k | | 04/14/2021 |
08/06/2020 | Compass Therapeutics, Inc. | CMPX | Grant | Stock Option (Right to Buy) | 30k | $5.00 | $150k | | 08/06/2020 |
05/20/2020 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 7.5k | $38.03 | $283.9k | | 05/20/2020 |
03/12/2020 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Common Stock | 20k | $28.76 | $575.2k | | 03/12/2020 |
02/27/2020 | Passage BIO, Inc. | PASG | Grant | Director Stock Option (Right to Buy) | 33.8k | $18.00 | $609k | | 02/27/2020 |
02/27/2020 | Passage BIO, Inc. | PASG | Grant | Employee Stock Option (Right to Buy) | 185.8k | $18.00 | $3.3M | | 02/27/2020 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 6.1M | $0.00 | $0 | See footnote | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Purchase | Common Stock | 275k | $18.00 | $5M | See footnote | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Common Stock | 1.1M | $0.00 | $0 | See footnote | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series A Convertible Preferred Stock | 6.1M | $0.00 | $0 | See footnote | 09/17/2019 |
09/17/2019 | SpringWorks Therapeutics, Inc. | SWTX | Conversion | Series B Convertible Preferred Stock | 1.1M | $0.00 | $0 | See footnote | 09/17/2019 |
09/12/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Stock Option (Right to Buy) | 30k | $18.00 | $539.7k | | 03/29/2019 |
03/29/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Series A Convertible Preferred Stock | 40M | $0.00 | $0 | See footnote | 03/29/2019 |
03/29/2019 | SpringWorks Therapeutics, Inc. | SWTX | Grant | Series B Convertible Preferred Stock | 6.9M | $0.00 | $0 | See footnote | 03/29/2019 |
08/24/2016 | Audentes Therapeutics, Inc. | BOLD | Grant | Stock Option (right to buy) | 9k | $15.03 | $135.3k | | 08/24/2016 |
10/27/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 3.8k | $188.36 | $723.5k | | 10/27/2014 |
10/27/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 2.1k | $189.00 | $391k | | 10/27/2014 |
10/27/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 2.5k | $42.66 | $105.6k | | 10/27/2014 |
10/27/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 3.1k | $78.88 | $242.6k | | 10/27/2014 |
10/03/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 5.1k | $169.95 | $866.7k | | 10/03/2014 |
10/03/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 4.9k | $174.95 | $861.6k | | 10/03/2014 |
10/03/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Exercise | Option to Purchase Common Stock | 10k | $42.66 | $427.7k | | 10/03/2014 |
09/24/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 76 | $159.50 | $12.1k | | 09/24/2014 |
08/04/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 1.7k | $157.42 | $261.6k | | 08/04/2014 |
02/28/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 4k | $0.00 | $0 | | 02/28/2014 |
02/28/2014 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Option to Purchase Common Stock | 49.2k | $176.80 | $8.7M | | 02/28/2014 |
|